• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[晕厥与癫痫发作]

[Syncope and epileptic seizures].

作者信息

Becker A, Noachtar S, Reithmann C, Brandt T, Steinbeck G

机构信息

Medizinische Klinik und Poliklinik I, Klinikum Grosshadern der Ludwig-Maximilians-Universität München.

出版信息

Internist (Berl). 2005 Sep;46(9):994, 996-1000, 1002-5. doi: 10.1007/s00108-005-1475-9.

DOI:10.1007/s00108-005-1475-9
PMID:16021407
Abstract

Syncope is one of the most common symptoms leading to hospital admission. Thereby syncope can be induced by several diseases. It is crucial to detect underlying structural heart disease or high grade arrhythmias, as these are associated with an increased mortality. The careful history and physical examination can often give sufficient evidence to evaluate the origin of syncope. Additional examinations should only be applied selectively. In patients with structural heart disease the specific treatment should be initiated, in patients with cardiac arrhythmias the implantation of a pacemaker or ICD might be indicated. The most common neurally-mediated and orthostatic syncopes can often be treated successfully by physical training. Beside syncope epilepsy might be responsible for a transient loss of consciousness. Again careful history taking helps to differentiate between these two entities.

摘要

晕厥是导致住院的最常见症状之一。晕厥可由多种疾病诱发。检测潜在的结构性心脏病或高度心律失常至关重要,因为这些与死亡率增加相关。仔细的病史采集和体格检查通常能提供足够的证据来评估晕厥的病因。仅应选择性地进行额外检查。对于有结构性心脏病的患者,应开始特定治疗;对于有心律失常的患者,可能需要植入起搏器或植入式心律转复除颤器(ICD)。最常见的神经介导性和体位性晕厥通常可通过体育锻炼成功治疗。除晕厥外,癫痫也可能导致短暂意识丧失。同样,仔细的病史采集有助于区分这两种情况。

相似文献

1
[Syncope and epileptic seizures].[晕厥与癫痫发作]
Internist (Berl). 2005 Sep;46(9):994, 996-1000, 1002-5. doi: 10.1007/s00108-005-1475-9.
2
Evaluation and management of syncope.晕厥的评估与处理
Minerva Cardioangiol. 2010 Dec;58(6):701-15.
3
[Neurological and psychiatric assessment of syncope].[晕厥的神经学和精神病学评估]
Herzschrittmacherther Elektrophysiol. 2011 Jun;22(2):83-6, 89-92. doi: 10.1007/s00399-011-0128-z. Epub 2011 Apr 22.
4
[Neuropediatric emergencies--epileptic seizures and acute hemiplegia].[神经儿科急症——癫痫发作与急性偏瘫]
Ther Umsch. 2005 Aug;62(8):565-70. doi: 10.1024/0040-5930.62.8.565.
5
Syncope: Evaluation and Differential Diagnosis.晕厥:评估与鉴别诊断。
Am Fam Physician. 2017 Mar 1;95(5):303-312.
6
Implantable loop recorder for recurrent syncopes.用于复发性晕厥的植入式循环记录仪。
Minerva Med. 2009 Aug;100(4):293-305.
7
Identifying patients with epilepsy at high risk of cardiac death: signs, risk factors and initial management of high risk of cardiac death.识别具有心脏性猝死高风险的癫痫患者:高危心脏性猝死的征象、危险因素和初始处理。
Epileptic Disord. 2021 Feb 1;23(1):17-39. doi: 10.1684/epd.2021.1254.
8
Additional diagnostic value of implantable loop recorder in patients with initial diagnosis of real or apparent transient loss of consciousness of uncertain origin.植入式循环记录仪在初始诊断为真实或明显的不明原因短暂意识丧失患者中的附加诊断价值。
Europace. 2014 Aug;16(8):1226-30. doi: 10.1093/europace/euu051. Epub 2014 Mar 25.
9
Anoxic-epileptic seizures: observational study of epileptic seizures induced by syncopes.缺氧性癫痫发作:晕厥诱发癫痫发作的观察性研究
Arch Dis Child. 2005 Dec;90(12):1283-7. doi: 10.1136/adc.2005.075408. Epub 2005 Sep 13.
10
Evaluation of syncope.晕厥评估。
Am Fam Physician. 2011 Sep 15;84(6):640-50.

本文引用的文献

1
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).ACC/AHA/NASPE 2002年心脏起搏器与抗心律失常器械植入指南更新:总结篇。美国心脏病学会/美国心脏协会实践指南工作组(ACC/AHA/NASPE 1998年起搏器指南更新委员会)报告。
J Cardiovasc Electrophysiol. 2002 Nov;13(11):1183-99. doi: 10.1046/j.1540-8167.2002.01183.x.
2
Guidelines on management (diagnosis and treatment) of syncope.晕厥管理(诊断与治疗)指南
Eur Heart J. 2001 Aug;22(15):1256-306. doi: 10.1053/euhj.2001.2739.
3
Diagnostic value of history in patients with syncope with or without heart disease.
病史对合并或不合并心脏病的晕厥患者的诊断价值。
J Am Coll Cardiol. 2001 Jun 1;37(7):1921-8. doi: 10.1016/s0735-1097(01)01241-4.
4
Head-up tilt testing potentiated with oral nitroglycerin: a randomized trial of the contribution of a drug-free phase and a nitroglycerin phase in the diagnosis of neurally mediated syncope.口服硝酸甘油增强的头高位倾斜试验:一项关于无药期和硝酸甘油期对神经介导性晕厥诊断贡献的随机试验
Europace. 1999 Jul;1(3):183-6. doi: 10.1053/eupc.1999.0036.
5
Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era.在植入式心脏复律除颤器时代,采用电生理引导方法治疗不明原因晕厥患者的长期预后。
J Am Coll Cardiol. 1999 Oct;34(4):1082-9. doi: 10.1016/s0735-1097(99)00323-x.
6
Pathophysiological basis of orthostatic hypotension in autonomic failure.自主神经功能衰竭时直立性低血压的病理生理基础。
J Physiol. 1999 Aug 15;519 Pt 1(Pt 1):1-10. doi: 10.1111/j.1469-7793.1999.0001o.x.
7
Increased orthostatic tolerance following moderate exercise training in patients with unexplained syncope.不明原因晕厥患者进行适度运动训练后体位性耐力增加。
Heart. 1998 Dec;80(6):596-600. doi: 10.1136/hrt.80.6.596.
8
The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope.北美血管迷走性起搏器研究(VPS)。一项关于永久性心脏起搏预防血管迷走性晕厥的随机试验。
J Am Coll Cardiol. 1999 Jan;33(1):16-20. doi: 10.1016/s0735-1097(98)00549-x.
9
The natural course of untreated sick sinus syndrome and identification of the variables predictive of unfavorable outcome.未经治疗的病态窦房结综合征的自然病程及预测不良结局的变量识别。
Am J Cardiol. 1998 Nov 15;82(10):1205-9. doi: 10.1016/s0002-9149(98)00605-5.
10
Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing.一项使用植入式循环记录仪的初步研究的最终结果,该研究旨在确定无创和有创检查结果均为阴性的晕厥患者的病因。
Am J Cardiol. 1998 Jul 1;82(1):117-9. doi: 10.1016/s0002-9149(98)00237-9.